Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QGEN

QIAGEN N.V.

CIK 0001015820 · NYSE

NYSEHealth CareBiological Products, (No Diagnostic Substances)
$41.99
↑ 3.99 (10.50%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Options; Excluded: Ownership (no data)

Key stats

Market Cap
$9.11B
P/E Ratio
21.44
EPS
1.96
Dividend Yield
5.5%
52W Position
37%
Beta
0.34

Valuation multiples

Fwd P/E
12.61
PEG
1.01
P/B
2.41
P/S
4.36
EV/Revenue
4.75
ROE
11.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 37%
$32.53$57.81

Latest Financials

2025-12-31 FY
Revenue
$2.09B
Net Income
$424.88M
Total Assets
$6.28B
Free Cash Flow
$453.28M

Recent news